L.P. ACORN BIOVENTURES - 22 Dec 2025 SCHEDULE 13G Report for Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA)

Filing Manager
L.P. ACORN BIOVENTURES
Reporting Manager
Anders Hove
Security
Athira Pharma, Inc. Common Stock, $0.0001 Par Value
Symbol
ATHA
Shares outstanding
9,648,827 shares
Disclosed Ownership
501,739 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
23 Dec 2025, 16:46:14 UTC
Date of event
22 Dec 2025
Next filing
08 Jan 2026
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 210,730 0 210,730 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 210,730 0 210,730 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3% 291,009 0 291,009 Anders Hove Manger of General Partner
Acorn Capital Advisors GP 2, LLC 3% 291,009 0 291,009 Anders Hove Manager
Anders Hove 5.2% 501,739 0 501,739 Anders Hove Individually